Analystreport

Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at BMO Capital Markets from $66.00 to $60.00.

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com